Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze GKOS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate GKOS investment potential.

What is GKOS stock price today?

Get real-time GKOS stock price, historical data, and price charts on Financhill. Track GKOS performance with our advanced analysis tools.

Is GKOS a good investment?

Evaluate GKOS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy GKOS stock?

To buy GKOS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of GKOS?

View detailed market capitalization data and company valuation metrics for GKOS on our comprehensive analysis page.

What is the P/E ratio of GKOS?

Use our fundamental analysis tools to view GKOS P/E ratio and compare valuation metrics with industry peers.

What are GKOS earnings?

View GKOS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Glaukos Corp. 10K Form

Buy

GKOS
Glaukos Corp.

Last Price:

$108.55

Seasonality Move:

7.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-07	10Q	GKOS/Glaukos Corp. Quarterly
2020-05-07	10Q	GKOS/Glaukos Corp. Quarterly
2020-03-02	10K	GKOS/Glaukos Corp. Annual
2019-11-06	10Q	GKOS/Glaukos Corp. Quarterly
2019-08-08	10Q	GKOS/Glaukos Corp. Quarterly
2019-05-08	10Q	GKOS/Glaukos Corp. Quarterly

Receive GKOS News And Ratings

See the #1 stock for the next 7 days that we like better than GKOS

GKOS Financial Statistics

Sales & Book Value

Annual Sales:	$383.5M
Cash Flow:	$-11.7M
Price / Cash Flow:	0
Annual Sales:	$13.41
Price / Book:	8.1

Profitability

EPS (TTM):	-1.55090
Net Income (TTM):	$-87.6M
Gross Margin:	$287.1M
Return on Equity:	-11.73%
Return on Assets:	-8.91%

Glaukos Corp. Earnings Forecast

Key Glaukos Corp. Financial Ratios

The Gross Profit Margin over the past 12 years for GKOS is 74.86%.
The Selling, General & Administrative Expenses for GKOS have been equal to 68.10% of Gross Profit Margin.
The Research & Development expenses have been 35.58% of Revenue.
The Net Earning history of GKOS is -38.17% of Total Revenues.
Per Share Earnings over the last 12 years have been positive in 5 years.

Glaukos Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Health Care Equipment & Supplies
Sector:	Health Care
Current Symbol:	GKOS
CUSIP:	377322
Website:	glaukos.com

Debt

Debt-to-Equity Ratio:	0.14
Current Ratio:	5.2
Quick Ratio:	4.35

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	9213.32

GKOS Technical Analysis vs Fundamental Analysis

Buy

Glaukos Corp. (GKOS) is a Buy

Is Glaukos Corp. a Buy or a Sell?

Glaukos Corp. stock is rated a Buy

The current Glaukos Corp. [GKOS] share price is $108.51. The Score for GKOS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.